J., M., P., C., B., G., A., L., A., M., M., S., . . . K., B. (2017). Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): A phase 3 randomised double-blind active-controlled trial.
Chicago Style CitationJ., Molina, et al. Rilpivirine Versus Efavirenz With Tenofovir and Emtricitabine in Treatment-naive Adults Infected With HIV-1 (ECHO): A Phase 3 Randomised Double-blind Active-controlled Trial. 2017.
MLA引文J., Molina, et al. Rilpivirine Versus Efavirenz With Tenofovir and Emtricitabine in Treatment-naive Adults Infected With HIV-1 (ECHO): A Phase 3 Randomised Double-blind Active-controlled Trial. 2017.
警告：這些引文格式不一定是100％准確.